Evaluation of low-dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for stem cell transplantation-Reference-Cited by-同舟云学术

Evaluation of low-dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for stem cell transplantation

Published:2015-11-04 Issue:2 Volume:13 Page:e138-e143
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Aznab Mozaffar¹,Rezaei Mansour²,Navabi Jafar¹,Moieni Ali¹

Affiliation:

1. Internal Medicine Department, Talaghani Hospital; Kermanshah University of Medical Science; Kermanshah Iran

2. Department of Biostatistics, Social Development and Health Promotion Research Center, Public Health College; Kermanshah University of Medical Sciences; Kermanshah Iran

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12418/fullpdf

Reference27 articles.

1. Treatment of relapsed/refractory multiple myeloma;Kastritis;Semin Hematol,2009

2. Relapsed multiple myeloma;Lonial;Hematology Am Soc Hematol Educ Program,2010

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

4. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;N Engl J Med,1999

5. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic;International Journal of Clinical Oncology;2020-07-11

2. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience;Journal of Oncology;2019-03-20